And hitting the road, covid19 complicates the lives of an increasing number of Older Americans traveling the country to find seasonal work. There is a Huge Population of us that are still in limbo wondering if there is a next job to go to. Judy all that and more on tonights pbs newshour. Major funding for the pbs newshour has been provided by when the world gets complicated a lot goes through your mind. With fidelity Wealth Management a dedicated advisor can tailor advice and recommendations to your life. That is fidelity Wealth Management. Consumer cellular. Johnson johnson. Financial Services Firm raymond james. Bnsf railway. The candida fund, committed to justice through investments in transformative leaders and ideas. More at candida fund. Org. Carnegie corporation of new york. Supporting innovations in education, democratic engagement and the advancement of International Peace and security at carnegie. Org. And with ongoing support of these individuals and institutions. This progr
And, hitting the road. Covid19 complicates the lives of an increasing number of Older Americans traveling the country to find seasonal work. Theres a Huge Population of us that are still in limbo, wondering if there is a next job to go to. Woodruff all that and more, on tonights pbs newshour. Major funding for the pbs newshour has been provided by when the world gets complicated, a lot goes through your mind. With fidelity wealth management, a dedicated advisor can tailor advice and recommendations to your life. Thats fidelity wealth management. Consumer cellular. Johon johnson. Financial Services Firm raymond james. Bnsf railway. The kendeda fund. Committed to advancing Restorative Justice and meaningful work through investments in transformative leaders and ideas. More at kendedafund. Org. Carnegie corporation of new york. Supporting innovations in education, democratic engagement, and the advancement of International Peace and security. At carnegie. Org. And with the ongoing support
Thank you everybody for coming. Please continue to enjoy your lunch. Im tim carney, im a visiting fellow here at the American Enterprise institute as well as being a the commentary ted tor at the Washington Examiner. Were here to talk about health care. But i want to ask a specific question about health care. And its a question that some people on the Free Enterprise side, the free market conservative or libertiarian side dont always ask. Kui, bono in latin, or who benefits. I think sometimes people on the right or right of center are uncomfortable with that question in policy debates because they say why should it matter who benefits . Because we see Elizabeth Warren will say a tax cut is bad because rich people benefit. But i think its actually a very important thing to talk about. One, it definitely influences our debates. If you remember in the 2008 campaign and the passage of obamacare, barack obama certainly thought it was very important to point out that he was battling, you kno
Ned sharpless. Washington post. This is about 1 hour and 40 minutes. Good morning. I am lori mcginley. I am a help than science reporter here at the washington post. I am delighted to be joined this morning by acting fda commissioner, dr. Ned sharpless. Thank you for being with us. Good morning. Thank for having a. Dr. Sharpless has been on the job a little over two months of the fda. Was previously the director of the National Cancer institute. Dr. Sharpless, let me start by asking, you been there a whole two months now. So, how do you hope to make your mark on the fda . I think maybe it is relevant to talk about my background that brought me to my job a little bit. I a cancer doctor. At some point, transition from taking my patients more in the lab from running in Academic Research lab cancer. I felt like we were, at that time, the progress of cancer was really slow and it was frustrating. From doing the same things over and over with patience. We were helping them. To the degree tha
Good morning. I am lori mcginley. I am a help than science reporter here at the washington post. I am delighted to be joined this morning by acting fda commissioner, dr. Ned sharpless. Thank you for being with us. Good morning. Thank for having a. Dr. Sharpless has been on the job a little over two months of the fda. Was previously the director of the National Cancer institute. Dr. Sharpless, let me start by asking, you been there a whole two months now. So, how do you hope to make your mark on the fda . I think maybe it is relevant to talk about my background that brought me to my job a little bit. I a cancer doctor. At some point, transition from taking my patients more in the lab from running in Academic Research lab cancer. I felt like we were, at that time, the progress of cancer was really slow and it was frustrating. From doing the same things over and over with patience. We were helping them. To the degree that i would have liked. Beyond became a researcher. And at some point d